000 01269 a2200349 4500
005 20250514194105.0
264 0 _c20050114
008 200501s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/j.ajkd.2004.06.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWarnock, David G
245 0 0 _aHypertension.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cAug 2004
300 _a369-75 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aComorbidity
650 0 4 _aDiet
650 0 4 _aExercise
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGoals
650 0 4 _aHumans
650 0 4 _aHyperaldosteronism
_xcomplications
650 0 4 _aHypertension
_xdiagnosis
650 0 4 _aKidney Diseases
_xcomplications
650 0 4 _aRisk Factors
700 1 _aTextor, Stephen C
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 44
_gno. 2
_gp. 369-75
856 4 0 _uhttps://doi.org/10.1053/j.ajkd.2004.06.002
_zAvailable from publisher's website
999 _c14966516
_d14966516